These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30311653)

  • 1. No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma.
    Yu TJ; Liu YY; Hu X; Di GH
    J Surg Oncol; 2018 Nov; 118(6):928-935. PubMed ID: 30311653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
    Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
    Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
    Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
    Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival following breast-conserving therapy is equal to that following mastectomy in young women with early-stage invasive lobular carcinoma.
    Yu TJ; Liu YY; Hu X; Di GH
    Eur J Surg Oncol; 2018 Nov; 44(11):1703-1707. PubMed ID: 30029824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.
    Kruper L; Kauffmann RM; Smith DD; Nelson RA
    Ann Surg Oncol; 2014 Oct; 21(11):3448-56. PubMed ID: 25047478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.
    Yang Y; Pan L; Shao Z
    Breast Cancer Res Treat; 2021 Dec; 190(3):503-515. PubMed ID: 34554371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast.
    Kizy S; Huang JL; Marmor S; Tuttle TM; Hui JYC
    Breast Cancer Res Treat; 2017 Oct; 165(3):757-763. PubMed ID: 28647915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.
    Jatoi I; Parsons HM
    Breast Cancer Res Treat; 2014 Nov; 148(2):389-96. PubMed ID: 25301088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy.
    Agarwal S; Pappas L; Matsen CB; Agarwal JP
    Cancer Med; 2020 Nov; 9(21):8043-8052. PubMed ID: 32918537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
    Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
    Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
    Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
    Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.
    Bedrosian I; Hu CY; Chang GJ
    J Natl Cancer Inst; 2010 Mar; 102(6):401-9. PubMed ID: 20185801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Wong SM; King T; Boileau JF; Barry WT; Golshan M
    Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Survival Outcomes in Young Patients With Breast Cancer Receiving Contralateral Prophylactic Mastectomy Versus Unilateral Mastectomy.
    Huang H; Wei T; Zhang A; Zhang H; Kong L; Li Y; Li F
    Clin Breast Cancer; 2023 Oct; 23(7):752-762.e7. PubMed ID: 37586925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0-1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database.
    Hu G; Hu G; Zhang C; Lin X; Shan M; Yu Y; Lu Y; Niu R; Ye H; Wang C; Xu C
    BMC Cancer; 2020 Feb; 20(1):136. PubMed ID: 32085753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.
    Ashfaq A; McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; McLaughlin SA; Casey WJ; Rebecca AM; Kreymerman P; Wasif N
    Ann Surg Oncol; 2014 Sep; 21(9):2934-40. PubMed ID: 24756811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
    Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
    Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends of incidence and mortality in metaplastic breast cancer and the effect of contralateral prophylactic mastectomy: A population-based study.
    Wu P; Chang H; Wang Q; Shao Q; He D
    Asian J Surg; 2024 Jan; 47(1):394-401. PubMed ID: 37739898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
    Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
    J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.